CVE-2024-41668

cBioPortal Proxy Endpoint Vulnerabliity

CVSS 8.3 HIGHEPSS 0.6%CWE-918

Vexday Risk Score

21Low

SSVC decision (CISA)

Track

No exploitation signal → monitor

CVSS 8.3EPSS 0.6%KEV nãoPoC —Nuclei —Metasploit —Patch —

Lifecycle

23 Jul 2024Published on NVD

Recommendation: Monitor — no exploitation signal at the moment.

The cBioPortal for Cancer Genomics provides visualization, analysis, and download of large-scale cancer genomics data sets. When running a publicly exposed proxy endpoint without authentication, cBioPortal could allow someone to perform a Server Side Request Forgery (SSRF) attack. Logged in users could do the same on private instances. A fix has been released in version 6.0.12. As a workaround, one might be able to disable `/proxy` endpoint entirely via, for example, nginx.

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:L/I:L/A:L

Affected products

cBioPortal · cbioportal

Want to know if your infrastructure is exposed to this?

Talk to TrueHacking →

References

https://github.com/cBioPortal/cbioportal/commit/ea8642fdbda2d61d2ab34b9da7a1594680bbbcd5 https://github.com/cBioPortal/cbioportal/pull/10884 https://github.com/cBioPortal/cbioportal/releases/tag/v6.0.12 https://github.com/cBioPortal/cbioportal/security/advisories/GHSA-9h44-r3c3-q7rm https://www.wizlynxgroup.com/security-research-advisories/vuln/WLX-2024-004